Covid-19 Research

Case Report

Aeromonas hydrophila Septicaemia in a 6-Month-Old Infant: A Case Report

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Case Report
Subject Medicine Group
OCLC JBRES Record
Williams Oluwatosin Adefila*, Isaac Osei, Keita Modou Lamin, Baleng Mahama Wutor, Yusuf Abdulsalam Olawale, Minteh Molfa, Ousman Barjo, Mayowa Omotosho, Rasheed Salaudeen and Grant Mackenzie
Issue: Volume5-Issue6
Pages: 640-644
Received: 2024-06-15
Accepted: 2024-06-16
Published: 2024-06-21

Abstract

Background: Aeromonas hydrophila, a Gram-negative, motile, facultative anaerobe, is emerging as a serious pathogen. It is found in water, soil, and food, causing various infections, from mild diarrhoea to life-threatening sepsis. Young children, older people, and immunocompromised people are most susceptible. While treatable with antibiotics, A. hydrophila’s growing resistance to penicillin and other commonly available antibiotics complicates treatment. This case report highlights a rare instance of A. hydrophila sepsis in a young child in rural Gambia.

Case summary: A 6-month-old African female child with high fever, cough, fast breathing, and vomiting was diagnosed with septicemia caused by Aeromonas hydrophila, a waterborne bacteria. The infant likely contracted the infection from contaminated fish or water. We started the child on the initial first-line empirical antibiotics but later switched to ceftriaxone due to antibiotic resistance, and the child recovered fully. This case highlights the importance of appropriate diagnosis, antibiotic susceptibility and surveillance of emerging antibiotic-resistant pathogens in young children.

Conclusion: This report describes the infection of emerging antibiotic-resistant A. hydrophila sepsis in an African female child. A. hydrophila is an emerging pathogen causing opportunistic infections in both immunocompetent and immunocompromised patients. This study suggests that prompt identification of bacterial pathogens, coupled with targeted antimicrobial therapy guided by local antibiogram data and blood culture for antibiotic susceptibility, is likely a crucial factor for optimal patient outcomes. Furthermore, we advocate for more comprehensive surveillance systems to effectively track and monitor these emerging antibiotic-resistant pathogens.

FullText HTML FullText PDF DOI: 10.37871/jbres1936 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Adefila WO, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Adefi la WO, Osei I, Lamin KM, Wutor BM, Olawale YA, Molfa M, Barjo O, Omotosho M, Salaudeen R, Mackenzie G. Aeromonas hydrophila Septicaemia in a 6-Month-Old Infant: A Case Report. J Biomed Res Environ Sci. 2024 Jun 21; 5(6): 640-644. doi: 10.37871/jbres1936, Article ID: JBRES1936, Available at: https://www.jelsciences.com/articles/jbres1936.pdf

Subject area(s)

PathologyPediatrics

References

  1. Pessoa RBG, de Oliveira WF, Correia MTDS, Fontes A, Coelho LCBB. Aeromonas and Human Health Disorders: Clinical Approaches. Front Microbiol. 2022 May 31;13:868890. doi: 10.3389/fmicb.2022.868890. PMID: 35711774; PMCID: PMC9195132.
  2. Liu J, Gao S, Dong Y, Lu C, Liu Y. Isolation and characterization of bacteriophages against virulent Aeromonas hydrophila. BMC Microbiol. 2020 Jun 1;20(1):141. doi: 10.1186/s12866-020-01811-w. PMID: 32487015; PMCID: PMC7268745.
  3. Semwal A, Kumar A, Kumar N. A review on pathogenicity of Aeromonas hydrophila and their mitigation through medicinal herbs in aquaculture. Heliyon. 2023 Feb 28;9(3):e14088. doi: 10.1016/j.heliyon.2023.e14088. PMID: 36938468; PMCID: PMC10018484.
  4. Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev. 2010 Jan;23(1):35-73. doi: 10.1128/CMR.00039-09. PMID: 20065325; PMCID: PMC2806660.
  5. Kaki R. A retrospective study of Aeromonas hydrophila infections at a university tertiary hospital in Saudi Arabia. BMC Infect Dis. 2023 Oct 9;23(1):671. doi: 10.1186/s12879-023-08660-8. PMID: 37814215; PMCID: PMC10563259.
  6. Sadeghi H, Alizadeh A, Vafaie M, Maleki MR, Khoei SG. An estimation of global Aeromonas infection prevalence in children with diarrhoea: a systematic review and meta-analysis. BMC Pediatr. 2023 May 22;23(1):254. doi: 10.1186/s12887-023-04081-3. PMID: 37217902; PMCID: PMC10201716.
  7. Grave I, Rudzate A, Nagle A, Miklasevics E, Gardovska D. Prevalence of Aeromonas spp. Infection in Pediatric Patients Hospitalized with Gastroenteritis in Latvia between 2020 and 2021. Children (Basel). 2022 Nov 2;9(11):1684. doi: 10.3390/children9111684. PMID: 36360412; PMCID: PMC9688984.
  8. Sinclair HA, Edwards F, Harris PNA, Heney C, Laupland KB. Epidemiology of Aeromonas Species Bloodstream Infection in Queensland, Australia: Association with Regional and Climate Zones. Microorganisms. 2022 Dec 22;11(1):36. doi: 10.3390/microorganisms11010036. PMID: 36677328; PMCID: PMC9867365.
  9. Citterio B, Francesca B. Aeromonas hydrophila virulence. Virulence. 2015;6(5):417-8. doi: 10.1080/21505594.2015.1058479. PMID: 26055576; PMCID: PMC4601520.
  10. Bhowmick UD, Bhattacharjee S. Bacteriological, Clinical and Virulence Aspects of Aeromonas-associated Diseases in Humans. Pol J Microbiol. 2018 Jun 30;67(2):137-149. doi: 10.21307/pjm-2018-020. PMID: 30015452; PMCID: PMC7256846.
  11. Morgan DR, Johnson PC, DuPont HL, Satterwhite TK, Wood LV. Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun. 1985 Oct;50(1):62-5. doi: 10.1128/iai.50.1.62-65.1985. PMID: 4044042; PMCID: PMC262135.
  12. Gan MY, Lee WL, Yap BJ, Seethor STT, Greenberg RG, Pek JH, Tan B, Hornik CPV, Lee JH, Chong SL. Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis. Front Pediatr. 2022 Jun 3;10:890767. doi: 10.3389/fped.2022.890767. PMID: 35722477; PMCID: PMC9204066.
  13. GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21. PMID: 36423648; PMCID: PMC9763654.
  14. Igbinosa IH, Igumbor EU, Aghdasi F, Tom M, Okoh AI. Emerging Aeromonas species infections and their significance in public health. ScientificWorldJournal. 2012;2012:625023. doi: 10.1100/2012/625023. Epub 2012 Jun 4. PMID: 22701365; PMCID: PMC3373137.
  15. Pang M. Editorial: Aeromonas spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment. Front Microbiol. 2023 Nov 2;14:1320343. doi: 10.3389/fmicb.2023.1320343. PMID: 38029149; PMCID: PMC10653320.
  16. El-Hossary D, Mahdy A, Elariny EYT, Askora A, Merwad AMA, Saber T, Dahshan H, Hakami NY, Ibrahim RA. Antibiotic Resistance, Virulence Gene Detection, and Biofilm Formation in Aeromonas spp. Isolated from Fish and Humans in Egypt. Biology (Basel). 2023 Mar 10;12(3):421. doi: 10.3390/biology12030421. PMID: 36979113; PMCID: PMC10045910.
  17. Neil B, Cheney GL, Rosenzweig JA, Sha J, Chopra AK. Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing. Appl Microbiol Biotechnol. 2024 Feb 13;108(1):205. doi: 10.1007/s00253-024-13055-z. PMID: 38349402; PMCID: PMC10864486.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership